帮助 关于我们

返回检索结果

妇科肿瘤患者负性情绪和元认知在躯体症状与恐惧疾病进展间的链式中介作用
Chain mediating effect of anxiety, depression and metacognition between somatic symptoms and fear of disease progression among gynecological tumor patients

查看参考文献31篇

张榴红 1,2,3   周婷 4   黄峥 1,2 *   张娴 5   张才溢 3  
文摘 目的探讨焦虑抑郁情绪和元认知在妇科肿瘤患者躯体症状与恐惧疾病进展间的链式中介作用。方法采用一般人口学资料、恐惧疾病进展简化量表(fear of progression questionnaire-short form,FoP-Q-SF)、医院焦虑抑郁量表(hospital anxiety and depression scale,HADS)、元认知问卷(metacognition questionnaire,MCQ)、躯体症状量表(somatic symptom scale,SSS)对208名妇科肿瘤患者进行调查。采用SPSS 25.0进行Pearson相关分析。采用SPSS PROCESS宏程序偏差校正的非参数百分位Bootstrap方法进行中介效应检验。结果妇科肿瘤患者恐惧疾病进展得分(32.41±10.43)分、抑郁得分(6.43±4.17)分、焦虑得分(7.51±4.10)分、元认知得分(68.44±16.04)分、躯体症状得分(20.58±15.70)分,48.56%的患者存在功能失调的恐惧疾病进展。相关分析显示,恐惧疾病进展与躯体症状(r=0.394,P<0.01)、焦虑(r=0.640,P<0.01)、抑郁(r=0.533,P<0.01)、元认知(r=0.489,P<0.01)均呈正相关。中介效应检验显示,焦虑抑郁情绪和元认知在妇科肿瘤患者躯体症状和恐惧疾病进展之间起完全链式中介作用。躯体症状对恐惧疾病进展的总效应为0.320;躯体症状通过影响焦虑情绪,进而影响元认知,间接影响恐惧疾病进展,中介效应值为0.242;躯体症状通过影响抑郁情绪,进而影响元认知,间接影响恐惧疾病进展,中介效应值为0.212。结论妇科肿瘤患者的躯体症状可以通过焦虑/抑郁和元认知的链式中介作用间接影响恐惧疾病进展。
其他语种文摘 Objective To explore the chain mediating effects of anxiety/depression and metacognition between somatic symptoms and fear of disease progression (FoP) in gynecological tumor patients. Methods A total of 208 gynecological tumor patients were investigated by general demographic data, fear of progression questionnaire-short form(FoP-Q-SF), hospital anxiety and depression scale(HADS), metacognition questionnaire(MCQ) and somatic symptom scale(SSS). SPSS 25.0 was used for Pearson correlation analysis. The significance of mediating effect was tested by deviation corrected nonparametric percentile Bootstrap method using SPSS macro program PROCESS. Results The scores of FoP-Q-SF, depression, anxiety, MCQ and SSS were (32.41±10.43), (6.43±4.17), (7.51±4.10), (68.44±16.04), (20.58±15.70) respectively. 48.56% of gynecological tumor patients had dysfunctional fear of disease progression. Correlation analysis showed that FoP was significantly positively correlated with somatic symptoms (r=0.394, P<0.01), anxiety (r=0.640, P<0.01), depression (r=0.533, P<0.01) and metacognition (r=0.489, P<0.01). Mediating effect test showed that anxiety, depression and metacognition played a complete chain mediating role between somatic symptoms and FoP in gynecological tumor patients.The total effect of somatic symptoms on FoP was 0.320. Somatic symptoms indirectly affected FoP by influencing anxiety and metacognition, and the intermediary effect value was 0.242. Somatic symptoms indirectly affected FoP by influencing depression and metacognition, and the intermediary effect value was 0.212. Conclusion Somatic symptoms can indirectly affect FoP through the chain mediation of anxiety/depression and metacognition.
来源 中华行为医学与脑科学杂志 ,2022,31(11):1002-1007 【扩展库】
DOI 10.3760/cma.j.cn371468-20220502-00221
关键词 妇科肿瘤 ; 恐惧疾病进展 ; 元认知 ; 焦虑情绪 ; 抑郁情绪 ; 躯体症状
地址

1. 中国科学院心理研究所, 中国科学院心理健康重点实验室, 北京, 100101  

2. 中国科学院大学心理学系, 北京, 100049  

3. 徐州医科大学附属医院神经内科, 徐州, 221006  

4. 北京大学医学人文学院医学心理学系, 北京, 100191  

5. 徐州医科大学附属医院放疗科, 徐州, 221004

语种 中文
文献类型 综述型
ISSN 1674-6554
学科 医药、卫生
文献收藏号 CSCD:7366065

参考文献 共 31 共2页

1.  Tauber N M. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol,2019,37(31):2899-2915 CSCD被引 6 次    
2.  Dinkel A. Fear of progression in cancer patients and survivors. Recent Results Cancer Res,2018,210:13-33 CSCD被引 9 次    
3.  Zhang L. The prevalence of psychological disorders among cancer patients during the COVID-19 pandemic: a meta-analysis. Psychooncology,2022 CSCD被引 1 次    
4.  Meissner V H. Fear of cancer recurrence and disease progression in long-term prostate cancer survivors after radical prostatectomy: a longitudinal study. Cancer,2021,127(22):4287-4295 CSCD被引 1 次    
5.  Pradhan P. The role of interpretation biases and symptom burden in fear of cancer recurrence/progression among ovarian cancer survivors. Psychooncology,2021,30(11):1948-1956 CSCD被引 1 次    
6.  Bubis L D. Symptom burden in the first year after cancer diagnosis: an analysis of patient-reported outcomes. J Clin Oncol,2018,36(11):1103-1111 CSCD被引 3 次    
7.  Butow P. Editorial: uncertainty,anxiety,and fear of cancer recurrence. Front Psychol,2021,12:811602 CSCD被引 1 次    
8.  周帅. 妇科癌症术后化疗病人身体意象现状及其影响因素研究. 护理研究,2021,35(2):306-310 CSCD被引 2 次    
9.  Wang Y H. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry,2020,25(7):1487-1499 CSCD被引 32 次    
10.  Hallet J. Patterns of symptoms burden in neuroendocrine tumors: a population-based analysis of prospective patient-reported outcomes. Oncologist,2019,24(10):1384-1394 CSCD被引 1 次    
11.  Mutlu H H. A comparison of metacognitive factors among patients with cancer and the control group. Psychooncology,2018,27(4):1277-1283 CSCD被引 1 次    
12.  Ng D. Fear of cancer recurrence among Chinese cancer survivors: prevalence and associations with metacognition and neuroticism. Psychooncology,2019,28(6):1243-1251 CSCD被引 1 次    
13.  Gormley M. An integrative review on factors contributing to fear of cancer recurrence among young adult breast cancer survivors. Cancer Nurs,2022,45(1):E10-E26 CSCD被引 2 次    
14.  Ranieri J. Role of metacognition thinking and psychological traits in breast cancer survivorship. Behav Sci (Basel),2020,10(9):135 CSCD被引 1 次    
15.  Wells A. Modelling cognition in emotional disorder: the S-REF model. Behav Res Ther,1996,34(11/12):881-888 CSCD被引 7 次    
16.  Anderson R. Testing relationships between metacognitive beliefs,anxiety and depression in cardiac and cancer patients: are they transdiagnostic?. J Psychosom Res,2019,124:109738 CSCD被引 1 次    
17.  Mahendran R. Validation of the English and simplified mandarin versions of the fear of progression questionnaire-short form in Chinese cancer survivors. BMC Psychol,2020,8(1):10 CSCD被引 1 次    
18.  Zhang M X. Validation of a Chinese version of the short form of metacognitions questionnaire (MCQ-30). J Affect Disord,2020,277:417-424 CSCD被引 1 次    
19.  Li Q. The Chinese version of hospital anxiety and depression scale: psychometric properties in Chinese cancer patients and their family caregivers. Eur J Oncol Nurs,2016,25:16-23 CSCD被引 8 次    
20.  Shen M H. Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients. BMC Cancer,2018,18(1):353 CSCD被引 1 次    
引证文献 1 篇

1 董雪红 赋能教育结合激励式心理干预对口腔癌手术患者情绪状态及生活质量的影响 中华行为医学与脑科学杂志,2024,33(12):1128-1135
CSCD被引 0 次

显示所有1篇文献

论文科学数据集
PlumX Metrics
相关文献

 作者相关
 关键词相关
 参考文献相关

版权所有 ©2008 中国科学院文献情报中心 制作维护：中国科学院文献情报中心
地址：北京中关村北四环西路33号 邮政编码：100190 联系电话：(010)82627496 E-mail:cscd@mail.las.ac.cn 京ICP备05002861号-4 | 京公网安备11010802043238号